Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs.

Autor: Forsberg EMV; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden., Riise R; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden., Saellström S; Department of Clinical Sciences, Swedish University of Agricultural Sciences, 75007 Uppsala, Sweden., Karlsson J; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, WA 6009, Australia., Alsén S; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden., Bucher V; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden., Hemminki AE; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.; Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, 00290 Helsinki, Finland., Olofsson Bagge R; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden., Ny L; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden., Nilsson LM; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, WA 6009, Australia., Rönnberg H; Department of Clinical Sciences, Swedish University of Agricultural Sciences, 75007 Uppsala, Sweden., Nilsson JA; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, WA 6009, Australia.

Publikováno v: Cancers [Cancers (Basel)] 2023 Jan 20; Vol. 15 (3). Date of Electronic Publication: 2023 Jan 20.

Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD.

Autor: Winslow S; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Odqvist L; Bioscience COPD/IPF, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Diver S; Dept of Respiratory Science, Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, UK., Riise R; Bioscience COPD/IPF, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Abdillahi S; Bioscience COPD/IPF, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Wingren C; Bioscience COPD/IPF, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Lindmark H; Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Wellner A; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Lundin S; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Yrlid L; Bioscience COPD/IPF, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Ax E; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Krefting Research Centre, Institute of Medicine at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Djukanovic R; NIHR Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences and Human Development and Health, University of Southampton, Southampton, UK., Sridhar S; Oncology Bioinformatics, Translational Science, Early Oncology, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Higham A; The University of Manchester Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and University Hospital of South Manchester, NHS Foundation Trust, Manchester, UK., Singh D; The University of Manchester Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and University Hospital of South Manchester, NHS Foundation Trust, Manchester, UK., Southworth T; The University of Manchester Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and University Hospital of South Manchester, NHS Foundation Trust, Manchester, UK., Brightling CE; Dept of Respiratory Science, Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, UK., Olsson HK; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Jevnikar Z; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden Zala.JevnikarRojnik@astrazeneca.com.

Publikováno v: The European respiratory journal [Eur Respir J] 2021 Oct 14; Vol. 58 (4). Date of Electronic Publication: 2021 Oct 14 (Print Publication: 2021).

Bleomycin hydrolase regulates the release of chemokines important for inflammation and wound healing by keratinocytes.

Autor: Riise R; Bioscience COPD/IPF, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Odqvist L; Bioscience COPD/IPF, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Mattsson J; Translational Science & Experimental Medicine, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Monkley S; Translational Science & Experimental Medicine, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Abdillahi SM; Bioscience COPD/IPF, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Tyrchan C; Medicinal Chemistry, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Muthas D; Translational Science & Experimental Medicine, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Yrlid LF; Bioscience COPD/IPF, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. linda.yrlid@astrazeneca.com.

Publikováno v: Scientific reports [Sci Rep] 2019 Dec 31; Vol. 9 (1), pp. 20407. Date of Electronic Publication: 2019 Dec 31.

Nordic research in ophthalmology

Autor: Heijl, A, Algvere, P V, Alms, A, Andersen, N, Bauer, B, Carlsson, J O, Ehinger, B, Eide, N, Fledelius, Hans, Foerster, M, Hjortdal, Jesper Østergaard, Holmstrom, G, Hovding, G, Kivela, T, laCour, M, Lindblom, B, Moller-Pedersen, T, Nikoskeleinen, E, Prause, J U, Riise, R, Rosenberg, T, Seregard, S, Stefansson, E, Tarkkanen, A, Tervo, T, Tornqvist, K, Zetterstrom, C

Publikováno v: Heijl, A, Algvere, P V, Alms, A, Andersen, N, Bauer, B, Carlsson, J O, Ehinger, B, Eide, N, Fledelius, H, Foerster, M, Hjortdal, J Ø, Holmstrom, G, Hovding, G, Kivela, T, laCour, M, Lindblom, B, Moller-Pedersen, T, Nikoskeleinen, E, Prause, J U, Riise, R, Rosenberg, T, Seregard, S, Stefansson, E, Tarkkanen, A, Tervo, T, Tornqvist, K & Zetterstrom, C 2005, ' Nordic research in ophthalmology ', Acta Ophthalmologica, no. 83(3), pp. 278-288 .

Nordic ophthalmologists and vision scientists are active in many fields of eye research. This is most evident at the biannual Nordic Congress of Ophthalmology, most recently held in Malmö in June 2004. The authors here review some of the research in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3b6e70e6d58706a18c9f2f33fbd1a8b6
https://pubmed.ncbi.nlm.nih.gov/15948777

Recent Advances in Molecular and Genetic Research on Uveal Melanoma.

Autor: Fuentes-Rodriguez, Aurélie^1,2,3,4 (AUTHOR) aurelie.fuentes-rodriguez.1@ulaval.ca, Mitchell, Andrew^1,2,3,4 (AUTHOR) andrew.mitchell@crchudequebec.ulaval.ca, Guérin, Sylvain L.^1,2,3 (AUTHOR) sylvain.guerin@fmed.ulaval.ca, Landreville, Solange^1,2,3,4 (AUTHOR) solange.landreville@fmed.ulaval.ca

Publikováno v: Cells (2073-4409). Jun2024, Vol. 13 Issue 12, p1023. 39p.